Certain aquatic insects can forewarn against possible outbreaks of diarrheal disease, shows study

Chironomids, a group of aquatic insects closely related to mosquitoes, act as natural reservoirs of disease-causing cholera bacteria and can forewarn against possible outbreaks of the diarrheal disease, a new study suggests.

Cholera— caused by the ingestion of food and water contaminated with Vibrio cholerae infects an estimated 1.3 to four million people around the world annually, resulting to as much as 143,000 deaths. Cholera is endemic in 50 countries, mostly in Africa and south and South-East Asia. According to WHO, of the many serogroups of V. cholerae, only two, O1 and O139, cause outbreaks.

Israeli researchers Meir Broza and Malka Halpern had reported earlier that chironomids harbour V. cholerae. But the new study, published 23 December in PLOS Neglected Tropical Diseases, establishes that chironomids form reservoirs for the toxigenic [cholera toxin-producing] serogroups O1 and O139.

The researchers assessed chironomids' capability to act as natural reservoirs of epidemic- and pandemic-causing O1/O139 serogroups of V. cholerae, by using molecular tools. They looked at 223 chironomid samples collected from India and Israel and found "the presence of V. cholerae serogroup O1 and cholera toxin genes in samples from all chironomid species".

However, V. cholerae serogroup O139 was detected in only two chironomid species, the researchers wrote in the study.

According to Halpern, an environmental microbiologist and a professor at the University of Haifa, monitoring and controlling chironomid populations in cholera endemic areas could potentially help predict and control outbreaks of the disease. She explains that chironomid populations peaked in spring and autumn followed by a relative increase in V. cholerae abundance in the insect.

"Cholera epidemics in the Bengal delta region also show a similar pattern of biannual [every spring and autumn] peaks," she notes.

Thus, a rise in chironomid populations in a cholera endemic area can predict a rise in V. cholerae abundance, Halpern tells SciDev.Net.

"[This] paper will bring new insights to a broad scientific community dealing with infectious diseases (e.g. epidemiologists, physicians and microbiologists) and may have an impact on [the] understanding of cholera pandemics, says senior co-author of the study, Bimalendu Nath, emeritus professor, department of zoology, Savitribai Phule Pune University, India.

"[Sampling] cum surveillance programme for chironomid population in different endemic areas of [cholera] in different parts of the world can be formulated which will be a novel tool for predicting the outbreak of cholera epidemics," Nath tells Scidev.Net.

Halpern recommends seasonal monitoring of chironomid populations and toxigenic V. cholerae serogroups.

The goal should be to find the threshold of chironomid population levels that will predict outbreaks and provide a tool for controlling cholera outbreaks in the future."

Malka Halpern, University of Haifa

Anil Kumar, clinical professor and head of the department of microbiology, Amrita Institute of Medical Sciences, Kerala, India, comments that the study provides 'proof-of-concept' to use chironomid populations as a surrogate indicator for predicting cholera outbreaks.

However, Kumar notes that despite finding V. cholerae in most of the chironomid species in the study samples, there were no reports of outbreaks.

"Therefore, the concept of using chironomid as a surrogate indicator for predicting cholera outbreaks needs to be tested in [cholera] endemic areas," he tells SciDev.Net.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New strategy uses bacteriophages to combat drug-resistant infections